BNP Paribas Exane Lowers Clorox (NYSE:CLX) Price Target to $95.00

Clorox (NYSE:CLX) had its price target reduced by analysts at BNP Paribas Exane from $97.00 to $95.00 in a research report issued on Monday,Benzinga reports. The firm currently has a “neutral” rating on the stock. BNP Paribas Exane’s price objective would suggest a potential downside of 0.75% from the stock’s current price.

A number of other brokerages also recently issued reports on CLX. Morgan Stanley lowered their price target on Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $91.00 price objective on shares of Clorox in a research report on Friday, May 1st. Royal Bank Of Canada lowered their target price on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a report on Thursday, April 9th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Clorox in a research report on Friday, July 10th. Finally, JPMorgan Chase & Co. cut their price target on shares of Clorox from $95.00 to $92.00 and set an “underweight” rating on the stock in a research note on Thursday, July 16th. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce” and a consensus target price of $103.40.

Clorox Stock Down 0.6%

Clorox stock opened at $95.72 on Monday. Clorox has a 1-year low of $84.70 and a 1-year high of $132.03. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The stock has a market cap of $11.57 billion, a PE ratio of 15.54 and a beta of 0.54. The stock’s fifty day moving average is $94.87 and its two-hundred day moving average is $103.98.

Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same period in the prior year, the firm posted $1.45 EPS. The business’s quarterly revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, sell-side analysts expect that Clorox will post 5.52 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Pierre R. Breber acquired 5,000 shares of Clorox stock in a transaction on Tuesday, May 5th. The stock was bought at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the purchase, the director owned 18,000 shares in the company, valued at $1,544,760. This represents a 38.46% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.63% of the company’s stock.

Hedge Funds Weigh In On Clorox

Institutional investors have recently modified their holdings of the business. Haverford Trust Co boosted its position in shares of Clorox by 2.8% in the 4th quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock valued at $310,000 after purchasing an additional 84 shares during the period. Field & Main Bank raised its holdings in Clorox by 3.3% during the 4th quarter. Field & Main Bank now owns 3,100 shares of the company’s stock worth $313,000 after buying an additional 100 shares during the period. Golden State Wealth Management LLC lifted its stake in Clorox by 28.2% during the fourth quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock valued at $46,000 after buying an additional 100 shares in the last quarter. Kestra Private Wealth Services LLC lifted its stake in Clorox by 1.8% during the first quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company’s stock valued at $617,000 after buying an additional 104 shares in the last quarter. Finally, Johnson Financial Group Inc. boosted its holdings in shares of Clorox by 3.1% in the third quarter. Johnson Financial Group Inc. now owns 3,659 shares of the company’s stock worth $451,000 after buying an additional 109 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.